Optimize Pricing Strategy, Maximize Access

Two Roads, One Journey

We help you to identify a clear pathway for reimbursement and adoption of your pharmaceutical and biotech products across major global healthcare markets

HEOR Consulting

Building your Optimax Pathway to Global Healthcare Markets

Optimax Access is a HEOR Consulting (Health Economics and Outcomes Research consultancy) company based in the United Kingdom, with an office in the Netherlands as well. We are a health economics company that assists our clients in introducing their pharmaceutical and biotech products and services to major global healthcare markets. As a HEOR Consulting Company, We will help you to identify a clear and optimal pathway to success with a comprehensive catalog of services ranging from clinical study design to reimbursement assessment, health economics evidence generation, and health technology assessment dossier submission.

Optimax Access
as a Health Economics Company,
assists you in 3 ways:

Early Market Access Assessment

We as a health economic consulting will help you in ensuring that your innovation will be fit for your target healthcare market at an early stage of development. Our services include early market access consulting for landscape assessment, early product value assessment, early payer engagement and communication with payer advisory boards, value dossier development, and the development of payer communication tools.

National Market Access Strategy

Assessing the added value of your new product or service is crucial to demonstrate this value to potential investors and decision-makers. We as a health economic consulting offer a range of services to help you achieve national market access, which include Health Technology Assessment (HTA) and reimbursement submissions, systematic and rapid literature reviews, cost-consequence and cost-effectiveness of health economic modeling, budget impact modeling, and publications in high-impact journals. We want to ensure that your product or service will achieve recommendations and endorsements from key healthcare actors and decision-makers in your country of interest.

Global Market Access Strategy

Launching a new product or service on a global scale comes with its own set of regulatory challenges. Only a health economics company can support you in the development of global value dossiers, core health economic modeling, and conducting country-specific adaptations of health economic models.